CAR T-cell therapy may slow neurodegenerative conditions like ALS
Illustration of CAR T-cell therapy (green) attacking a cancer cell (pink) NEMES LASZLO/SCIENCE PHOTO LIBRARY Genetically engineered immune cells known as CAR-T cells might be able to slow the progress of the neurodegenerative condition amyotrophic lateral sclerosis (ALS) by killing off rogue immune cells in the brain. “It’s not a way to cure the disease,”…
